BioScan AI (BioScanAI Innovative Solutions Private Limited)

BioScan AI is an Indian health-tech company that specializes in developing AI-powered, non-invasive diagnostic tools. The company focuses on bridging the gap in healthcare diagnostics by providing end-to-end solutions—from hardware to software—that enable early disease detection in low-resource settings without the need for on-site specialists. Their flagship products include 'Drishti AI,' which analyzes retinal images to detect conditions such as diabetic retinopathy, chronic kidney disease, cardiovascular disease, and Alzheimer's, and 'AutoThermix,' a thermal imaging solution for the early detection of breast cancer. The company is ISO 13485 certified and emphasizes accessibility, speed, and affordability in its diagnostic workflows.